Flare Therapeutics and Roche Forge Strategic Partnership to Discover Precision Oncology Therapies Targeting Transcription Factors

FDA Approves Autolus’s CAR-T Therapy Aucatzyl for Relapsed or Refractory B-ALL in Adults

Biosimilars: Expanding Access to Precision Medicine through Affordable Biologic Therapies

IDEAYA Biosciences Secures Exclusive Worldwide License for Biocytogen’s BsADC Program IDE034 for Solid Tumor Treatment

Seer and Thermo Fisher Scientific Announce Strategic Collaboration to Advance Proteomics with Integrated Platform Solution

SystImmune Secures FDA Clearance for IND Application of Novel ADC Therapy BL-M17D1 for Advanced Solid Tumors

Medicare Expands Coverage for Adaptive Biotechnologies' clonoSEQ® MRD Test to Include Mantle Cell Lymphoma

Illumina and PHASE Partner to Advance Oncology Testing in the Greater Bay Area, Supporting the "Healthy China" Initiative

MGI Partners with Human Cell Atlas to Advance Global Human Cell Mapping

NHS Wales and Illumina Expand Partnership to Advance Genomic Cancer Detection and Personalized Medicine

Unlocking Genomic Potential for Rare Cancers: Cancer52 and Genomics England’s Collaborative Approach

Tempus AI Launches Immune Profile Score to Enhance Precision in Immunotherapy for Advanced Cancer Patients

Key Resources and Organizations for Precision Medicine Guidelines

MedGenome Strengthens Leadership Team to Drive North American Expansion in Precision Medicine

NCCN Expands Clinical Practice Guidelines for High-Risk Genetic Cancer Assessment

Home
/
update
/
details

Apollo Hospitals Unveils Research Academy to Pioneer Global Healthcare Innovation

NextEdge Admin

05 Sep 2024

1 min 55 sec

Research,Digital Health,Precision Medicine

Apollo Hospitals has announced the launch of the Apollo Research Academy, an ambitious initiative designed to position Apollo as a global leader in healthcare research and innovation. Led by Professor Ravi P Mahajan CBE, the Academy will unify efforts across various Apollo entities, including the Apollo Health Education and Research Foundation (AHERF), Apollo University, ARI, Apollo Research Centre, and Apollo Clinical Innovation Group. This initiative aims to create a cohesive hub of research excellence recognized internationally.

The Academy will focus on five key areas: Capacity and Culture, Sponsored Research, Investigator-Driven Research, Data Sciences, and Innovation. These areas will be developed through a strategic framework that emphasizes fostering a culture of education, skill development, and resource sharing to drive collaborative projects within and beyond the Apollo ecosystem. It will expand sponsored research through partnerships with Contract Research Organizations (CROs) and build national and international consortiums to enhance investigator-driven research. Additionally, the Academy aims to establish a globally recognized Centre for Digital Health and Precision Medicine, focusing on innovation, research outputs, and grant funding. It will also nurture innovation hubs and incubators, fostering talent and partnerships to turn innovative ideas into tangible healthcare solutions.